|
CA2925305A1
|
|
Combination therapy with a6 and chemotherapeutic agents for the treatment of cancer
|
|
AU2011223563A1
|
|
Modulation of intracellular signaling
|
|
WO2010102253A2
|
|
Compositions and methods for modulation of cell migration
|
|
US2004204348A1
|
|
Cyclic peptide ligands that target urokinase plasminogen activator receptor
|
|
US6936587B1
|
|
Anti-invasive and anti-angiogenic compositions
|
|
WO02069885A2
|
|
Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
|
|
EP1218496A2
|
|
DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR
|
|
US6896870B1
|
|
Diagnostic probes and therapeutics targeting uPA and uPAR
|
|
US6277818B1
|
|
Cyclic peptide ligands that target urokinase plasminogen activator receptor
|
|
US5994309A
|
|
Anti-invasive and anti-angiogenic compositions and methods
|
|
US5942492A
|
|
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
